Sobi
Presence
Investor AB is one of the...
Investor AB is a company listed under the stock ticker INVEb.ST (SE).
Investor AB has a direct presence in 7 countries.Investor AB has 15 subsidiaries including Aequus Pharma, CTI BioPharma and CTI Life Sciences.
They are in:
- Healthcare31%
- Pharmaceuticals25%
- Other44%
Acquisition, funding and merger involving Investor AB.
- Sobi has acquired CTI BioPharma (posted on June 27 2023).
- Sobi has announced the acquisition of CTI BioPharma (posted on May 10 2023).
Executives
View the org chart displaying its 70 main executives
Most searched biographies at Sobi
- Guido Oelkers, President and Chief Executive Officer
- Helena Saxon, Director
- Annette Clancy, Chairman of the Board
Popular executive movements at Sobi
- Bo Jesper Hansen, Chairman of the Board, has left the company (posted on January 5 2024).
- Annette Clancy, who was Director, is promoted to Chairman of the Board (posted on January 5 2024).
- Lydia Abad-Franch, who was Vice President and Head Global Medical Affairs & Clinical Science, is promoted to Head of R&D and Chief Medical Officer (posted on October 5 2023).
Popular executive movements at Investor AB
- Christian Cederholm who is Head Patricia Industries, will be promoted to President and Chief Executive Officer on May 7, 2024 (posted on December 4 2023).
- Johan Forssell, Chief Executive Officer and Director, will leave the company on May 7, 2024 (posted on October 20 2023).
- Jacob Lund will join the company as Head of Corporate Communication & Sustainability in Oct. 2023 (posted on August 17 2023).
Click here to view some more movements at Investor AB
Create your alert
to follow the executive moves at Sobi.
Pharmaceuticals
Investor AB has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Sobi
- Sobi publishes Annual and sustainability report for 2023
- Press releases
- Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
- Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP
- Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
- Press releases
- Sobi and Handok establish joint venture for rare disease business in South Korea
- Sobi to present new data at EAHAD 2024
- Invitation: Sobi's Q4 and FY 2023 report
- Sobi's Chairman of the Board resigns due to health reasons
- View more press releases Close
Social media about Sobi
- Sobi on Wikipedia, Google News & Yahoo Finance
- Sobi on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Guido Oelkers 
